Webinars by the Innovative Medicines Initiative (IMI)

05/12/2017 17:50

Innovative Medicines Initiative (IMI) has been holding webinars on IMI2 from 27th of November. All webinars will feature a presentation by the European Federation of Pharmaceutical Industries and Associations (EFPIA), and will include time for questions and answers. The webinars represent an excellent opportunity to learn more about the Call topics, to interact directly with the topic coordinators, and to get in touch with potential project partners.

The webinar on IMI’s rules and procedures will include presentations of IMI's intellectual property policy and tips on the preparation of proposal submissions. IMI will also hold a dedicated webinar for small and medium-sized enterprises (SMEs). This will cover elements of the different Call topics that may be of particular relevance for SMEs, as well as a presentation of IMI’s rules and procedures with a focus on aspects that are most important for SMEs. The slides presented will be published, along with recordings of all webinars.


IMI rules & procedures

  • Thursday 7 December, 15:00 - 16:30
    This webinar is now full. The slides and recording will be published here. A second webinar on our rules and procedures will be scheduled for early 2018.


Opportunities for SMEs in IMI2 – Call 13

  • Thursday 7 December, 10:00 – 11:30
  • Pilot programme on a clinical compound bank for repurposing. This programme includes the following topics: cardiovascular diseases and diabetes; respiratory diseases; neurodegenerative diseases; rare/orphan diseases
    Wednesday 6 December, 10:30 - 12:00
  • A sustainable European induced pluripotent stem cell platform
    Monday 11 December, 10:30 - 12:00
  • CONCEPTION – continuum of evidence from pregnancy exposures, reproductive toxicology and breastfeeding to improve outcomes now
    Monday 11 December, 15:00 - 16:30
  • Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
    Tuesday 12 December, 15:00 - 16:30

Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice
Thursday 14 December, 10:30 - 12:00

  • Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
    Thursday 14 December, 15:00 - 16:30
  • The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
    Friday 15 December, 10:30 - 12:00
  • Genome-environment interactions in inflammatory skin disease
    Friday 15 December, 15:00 - 16:30